3Yoichiro O. Chemoradiotherapy for lung cancer[J]. Expert Opin on Pharmacother, 2005, 6(16) :2793-2804.
4Calvert H. MTA, a novel multitargeted antifolate, from preclini cal to phase Ⅰ and beyond: summary and conclusions[J]. Semin Oncol, 1999,26(suppl): 105-108.
5Smit E F, Mattson K, von Pawel J, et al. ALIMTA (pemetrexcd disodium) as second line treatment of non-small cell lung cancer: a phase Ⅱ study[J]. Ann Oncol,2003,14(3):455-460.
6Hanna N,Shepherd F A,Fossella F V, et al. Randomized phase Ⅲ trial of pernetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J]. J Clin Oncol,2004,22(9) :1589-1597.
7Manegold C,Gatzemeier U, von Pawel J, et al. Front line treat ment of advanced non-small cell with MTA(LY231514. peme trexcd disodium. ALIMTA) and cisplatin: a multicenter phase Ⅱ trial[J]. Ann Oncol,2000,11(4):435-440.
8Clarke S J,Abratt R,Goedhals L,et al. Phase Ⅱ trial of pemetrexed disodium(ALIMTA, LY231514) in chemotherapynaive padents with advanced non small cell lung cancer[J]. Ann Oncol 2002,13(5): 737-741.
9Monnerat C, Le Chevalier T, Kelly K, et al. Phase Ⅱ study of pemetrexed-gemcitabine combination in patients with advanced stage non small cell lung cancer[J]. Clin Cancer Res, 2004, 10 (16):5439-5446.
10Scagliotti G V. Pemetrexed plus carboplatin or oxaliplatin in ad vanced non-small-cell lung cancer[J]. Semin Oncol, 2005,32(2 Suppl 2) :S5-S8.
